Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomised, double-blind, placebo-controlled phase 2/3 Trial.
Wang H, Wang G, Gao Y, Qu L, Wang H, Deng M, Gao H, Li Y, Yang N, Wang B, Liu R, Ma X, Tao Z, Zhang G, Wang Q, Zhao W, Yu Y, Chen L, Liang L, Wang S, Shao L, Yang T, Cao J, Cao Y, Qin X, Ai J, Zhu H, Zhang W.
Wang H, et al. Among authors: shao l.
Clin Microbiol Infect. 2024 Oct 26:S1198-743X(24)00502-0. doi: 10.1016/j.cmi.2024.10.020. Online ahead of print.
Clin Microbiol Infect. 2024.
PMID: 39490410